JPH03224574A - Tube containing contrast media - Google Patents

Tube containing contrast media

Info

Publication number
JPH03224574A
JPH03224574A JP2021806A JP2180690A JPH03224574A JP H03224574 A JPH03224574 A JP H03224574A JP 2021806 A JP2021806 A JP 2021806A JP 2180690 A JP2180690 A JP 2180690A JP H03224574 A JPH03224574 A JP H03224574A
Authority
JP
Japan
Prior art keywords
bismuth
layer
synthetic resin
white
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021806A
Other languages
Japanese (ja)
Other versions
JP2839617B2 (en
Inventor
Mitsuru Samejima
満 鮫島
Shingo Ikeda
真吾 池田
Yoshisato Goshiki
慶悟 五色
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Junkosha Co Ltd
Original Assignee
Junkosha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Junkosha Co Ltd filed Critical Junkosha Co Ltd
Priority to JP2021806A priority Critical patent/JP2839617B2/en
Publication of JPH03224574A publication Critical patent/JPH03224574A/en
Application granted granted Critical
Publication of JP2839617B2 publication Critical patent/JP2839617B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the tube being white and having a high contrast effect and to prevent it from being discolored with the lapse of time by constituting the tube by forming the inside layer by a tubular synthetic resin in which a fluid passage is formed in the inside, forming the intermediate layer by dispersing an X-ray contrast media in the synthetic resin and giving ultraviolet ray transmission resistance to the outside layer and forming the tube consisting of three layers. CONSTITUTION:An inside layer 1 consists of a tubular synthetic resin in which a fluid passage 4 is formed in the inside, and an ethylene tetrafluoride copolymerization resin is used. An intermediate layer 2 is formed by dispersing an X-ray contrast-media consisting of white bismuth into a synthetic resin, and a white bismuth compound is a white bismuth crystal consisting of bismuth oxide, bismuth nitrate and bismuth sulfate, and that which is 83-88weight% bismuth content is used, and by dispersing and mixing it is a synthetic resin within a range of 3-25weight%, the inside layer 1 is covered. The outside of the intermediate layer 2 is covered with an outside layer 3 formed by dispersing and mixing titanium oxide of 0.05-1.0mum particle size by 0.5-2.0weight% in the synthetic resin. In such a way, the appearance shows white and at the time of using it for the human body, there is no sense of incompatibility, ultraviolet rays are prevented as to its transmission by the outside layer 3, and yellowing of white bismuth is prevented.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 この発明は、特に医療用の造影剤入チューブであって、
X線造影剤を管壁内に含んで造影効果を高め、且つ前記
造影剤の外側の層に紫外線透過抵抗性を備えて前記造影
剤の変色を抑制する。
[Detailed Description of the Invention] [Industrial Application Field] This invention relates to a contrast medium-containing tube particularly for medical use,
An X-ray contrast agent is included in the tube wall to enhance the contrast effect, and the outer layer of the contrast agent is provided with UV transmission resistance to suppress discoloration of the contrast agent.

〔従来の技術〕[Conventional technology]

ふっ素樹脂等の生体適合性がよい高分子材料に、硫酸バ
リウムや酸化ビスマスなどのX線造影剤を混入したチュ
ーブは、例えば輸液や輸血を行うときに血管に穿刺固定
する留置針として利用されている。かかる留置針は、使
用中にその一部が誤って切断され身体内の血管系に混入
しても、管壁内に含まれているX線造影剤によりレント
ゲン写真を用いて容易にその所在を確認することができ
る。
Tubes made of biocompatible polymer materials such as fluororesin mixed with X-ray contrast agents such as barium sulfate or bismuth oxide are used as indwelling needles that are inserted and fixed into blood vessels when administering fluids or blood transfusions, for example. There is. Even if a part of such an indwelling needle is accidentally cut off during use and enters the body's vascular system, its location can be easily detected using an X-ray photograph due to the X-ray contrast agent contained within the tube wall. It can be confirmed.

また、心臓からの血液採取や内蔵への薬剤注入などの目
的で、前記チューブを人体中に挿入してX線で透視しな
がら先端を目的の部位まで到達させるカテーテルとして
も利用されている。
It is also used as a catheter in which the tube is inserted into the human body and its tip reaches the target site while being viewed through X-rays for purposes such as collecting blood from the heart or injecting medicine into internal organs.

従来、この種の造影剤入チューブとしては、特公昭47
−49394号公報に記載されるように、X線造影剤を
管壁全体に一様に分散させてなるものや、特開昭56−
1)9263号公報に記載されるように、X線造影剤を
含む樹脂層の内面と外面にX線造影剤を含まない樹脂層
を一体に設けたもの、さらに実開昭51−108389
号公報に記載されるように、管壁の周方向の一部に長手
方向に連続するX線造影剤の混入部を設けたもの等が知
られている。
Conventionally, this type of contrast medium-containing tube was manufactured by
As described in Japanese Patent Publication No. 49394, there are those in which an X-ray contrast agent is uniformly dispersed throughout the tube wall, and the
1) As described in Publication No. 9263, a resin layer containing an X-ray contrast agent is integrally provided with a resin layer not containing an X-ray contrast agent on the inner and outer surfaces, and furthermore, a resin layer containing no X-ray contrast agent is provided on the inner and outer surfaces of the resin layer containing an X-ray contrast agent.
As described in Japanese Patent Publication No. 2003-121033, there is known a device in which a part of the tube wall in the circumferential direction is provided with an X-ray contrast agent mixed portion that is continuous in the longitudinal direction.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

ところで、X線造影剤入チューブに使用される造影剤と
しては、硫酸バリウムやビスマス化合物が一般的である
。特にビスマス化合物は硫酸バリウムよりも造影効果が
高いために、少量の配合で高い造影効果を得るには好適
である。
By the way, barium sulfate and bismuth compounds are generally used as contrast agents in tubes containing X-ray contrast agents. In particular, since bismuth compounds have a higher contrast effect than barium sulfate, they are suitable for obtaining high contrast effects with a small amount of compounding.

しかし、ビスマス化合物中で最もビスマス含有率が高く
て造影効果の高い酸化ビスマスは黄色を呈しているため
に、白色の硫酸バリウムに比べると医師や患者の生理的
感情から忌避されることがあるという問題点がある。
However, because bismuth oxide, which has the highest bismuth content among bismuth compounds and has the highest contrast effect, is yellow in color, it is sometimes avoided by doctors and patients due to their physiological feelings compared to barium sulfate, which is white. There is a problem.

また造影剤式チューブの種類を色で識別できるように着
色する場合においても、酸化ビスマスを使用したチュー
ブは黄色以外に着色して識別を可能にすることができな
いという問題点もある。
Further, even when coloring contrast medium type tubes so that they can be identified by color, there is a problem in that tubes using bismuth oxide cannot be colored in colors other than yellow to enable identification.

一方、ビスマス化合物の中で白色を呈している次炭酸ビ
スマスやオキシ塩化ビスマスは、酸化ビスマスに比べて
ビスマス含有率が低いため造影効果が低い。しかもこれ
らのビスマスは高温で分解するため成形温度の高いふっ
素樹脂に混入させることはできない。そこで、白色で造
影効果の高いビスマス系のX線造影剤入チューブが特願
平1−103065号として提案された。しかしこのチ
ューブは製造工程で分解や発泡を生ぜず外観も白色であ
るが、経時的に黄変するという問題がある。
On the other hand, among bismuth compounds, bismuth subcarbonate and bismuth oxychloride, which are white in color, have a lower contrast effect because they have a lower bismuth content than bismuth oxide. Moreover, since these bismuths decompose at high temperatures, they cannot be mixed into fluororesins whose molding temperatures are high. Therefore, a tube containing a bismuth-based X-ray contrast agent that is white and has a high contrast effect was proposed in Japanese Patent Application No. 1-103065. However, although this tube does not decompose or foam during the manufacturing process and has a white appearance, it has the problem of yellowing over time.

この発明は、チューブの前記黄変の原因が、紫外線によ
り白色ビスマス化合物が黄変することにあるという発明
者らの知見に基づいてなされたものであり、白色で造影
効果が高く、且つ経時的に変色することのない造影剤式
チューブを提供することを目的としている。
This invention was made based on the inventors' knowledge that the cause of the yellowing of the tube is that the white bismuth compound yellows due to ultraviolet rays. The purpose of this invention is to provide a contrast agent tube that does not discolor.

〔課題を解決するための手段〕[Means to solve the problem]

そこでこの発明は、内側層を、内部に流体通路が形成さ
れた管状合成樹脂から構成し、その外側の中間層を、合
成樹脂内にビスマス化合物からなるX線造影剤を分散さ
せて構成し、さらにその外側の外側層を、紫外線透過抵
抗性を付与して構成して、3層からなる造影剤式チュー
ブとしたちのである。
Therefore, in this invention, the inner layer is made of a tubular synthetic resin with a fluid passage formed therein, and the outer intermediate layer is made by dispersing an X-ray contrast agent made of a bismuth compound in the synthetic resin. Furthermore, the outer layer is made to be resistant to ultraviolet light transmission, resulting in a three-layer contrast agent type tube.

紫外線透過抵抗性を有する外側層を、合成樹脂内に酸化
チタンを分散させて構成すると好適である。
The outer layer having UV transmission resistance is preferably constructed by dispersing titanium oxide in a synthetic resin.

〔作用〕[Effect]

この発明の造影剤式チューブは、管状をなす内側層の内
部流体通路に血液や薬剤等の流体を通してカテーテル等
の用途に供する。中間層にはビスマス化合物からなるX
線造影剤が分散されているため造影効果が高く、従って
人体内におけるチューブの位置をX線写真やXkli視
により確実に認識することができる。また外側層に紫外
線透過抵抗性(紫外線遮蔽機能)をもたせているため、
中間層への紫外線の到達を抑制するから、前記ビスマス
化合物の黄変を防止してチューブを白色に維持する。前
記ビスマス化合物として白色のものを使用すると、造影
剤式チューブの白色度合をさらに鮮明に維持することが
できる。
The contrast medium type tube of the present invention is used for applications such as catheters by passing fluids such as blood and drugs through the internal fluid passageway of the inner layer having a tubular shape. The intermediate layer contains X made of bismuth compound.
Since the radiographic contrast agent is dispersed, the contrast effect is high, and therefore the position of the tube within the human body can be reliably recognized by X-ray photography or XKLI vision. In addition, the outer layer has UV transmission resistance (UV shielding function), so
Since it suppresses ultraviolet rays from reaching the intermediate layer, yellowing of the bismuth compound is prevented and the tube remains white. If a white bismuth compound is used, the degree of whiteness of the contrast medium type tube can be maintained even more clearly.

外側層の紫外線透過抵抗性を酸化チタンにより付与し、
これを合成樹脂内に分散させて外側層を構成すると、酸
化チタンは紫外線透過抵抗性が高いばか融点も高いため
に、前記合成樹脂として、熱可塑性であり且つ生体適合
性がよいふっ素樹脂を使用できる。このため、外側層の
形成が容易で且つ人体への使用に適するばかりか、高温
殺菌にも供し得る。
Titanium oxide imparts ultraviolet transmission resistance to the outer layer,
When this is dispersed in a synthetic resin to form the outer layer, titanium oxide has high UV transmission resistance and a high melting point, so a fluororesin, which is thermoplastic and has good biocompatibility, is used as the synthetic resin. can. Therefore, the outer layer is not only easy to form and suitable for use on the human body, but also can be subjected to high temperature sterilization.

〔実施例〕〔Example〕

第1図は造影剤式チューブの拡大断面図であり、このチ
ューブとしては、人体への輸液、輸血等に使用する硬質
の留置針や、人体に使用する可視性あるカテーテル等を
具体例とすることができる。
Figure 1 is an enlarged cross-sectional view of a contrast agent tube. Specific examples of this tube include hard indwelling needles used for infusions and blood transfusions into the human body, and visible catheters used in the human body. be able to.

これらの場合には径や管壁の厚み等の条件が相違するこ
とは勿論である。
Of course, conditions such as diameter and tube wall thickness are different in these cases.

このチューブは内側層1と、その外側の中間層2と、さ
らにその外側層3の3層からなり、内側層1の内径は0
.96mm、内側層1の外径と中間層2の内径は1.0
8鶴、中間層2の外径と外側層3の内径は1.20m、
外側層3の外径は1.32 mWに設定しであるが、こ
れらの寸法は一例であって、この種のチューブとしては
外径が小さく且つ内径が大きく、さらに機械的強度が高
いことが要求される。内側層lは内部に薬剤、血液等の
輸送路をなす流体通路4が形成された管状の合成樹脂か
らなり、この実施例ではふっ素樹脂、特に四ふっ化エチ
レン共重合樹脂(ETFE)を使用しているが、他のふ
っ素樹脂、例えば四ふっ化エチレン六ふっ化プロピレン
共重合樹脂、四ふっ化エチレンパーフルオロアルキルビ
ニルエーテル共重合樹脂、4ふっ化エチレン樹脂、ぶつ
化ビニリデン樹脂等を使用することができるし、また造
影剤入チューブの用途に応じてはふっ素樹脂以外の合成
樹脂を使用することもできる。
This tube consists of three layers: an inner layer 1, an intermediate layer 2 on the outside, and an outer layer 3. The inner diameter of the inner layer 1 is 0.
.. 96mm, the outer diameter of inner layer 1 and the inner diameter of middle layer 2 are 1.0
8 Tsuru, the outer diameter of the middle layer 2 and the inner diameter of the outer layer 3 are 1.20 m,
The outer diameter of the outer layer 3 is set to 1.32 mW, but these dimensions are just an example, and this type of tube should have a small outer diameter, a large inner diameter, and high mechanical strength. required. The inner layer 1 is made of a tubular synthetic resin in which a fluid passage 4 that serves as a transport path for drugs, blood, etc. is formed, and in this embodiment, a fluororesin, particularly tetrafluoroethylene copolymer resin (ETFE) is used. However, other fluororesins such as tetrafluoroethylene hexafluoropropylene copolymer resin, tetrafluoroethylene perfluoroalkyl vinyl ether copolymer resin, tetrafluoroethylene resin, vinylidene butonide resin, etc. can be used. However, depending on the purpose of the contrast medium-containing tube, synthetic resins other than fluororesin can also be used.

前記内側層1の外側に設けられる中間層2は、白色ビス
マスからなるX線造影剤を合成樹脂内に分散させてなる
。この合成樹脂としてここでは内側層1と同様に四ふっ
化エチレン共重合樹脂を使用しているが、他の合成樹脂
を使用することができることも前記同様である。白色ビ
スマス化合物は、酸化ビスマス、硝酸ビスマス及び硫酸
ビスマスからなる白色ビスマス混品物であって、ビスマ
ス含有率が83〜88重量%のものを使用し、この白色
ビスマス化合物を3〜25重量%の範囲で前記合成樹脂
に分散配合して、前記内側層lを被覆する。前記白色ビ
スマス化合物は耐熱性であり生体適合性がよい。
The intermediate layer 2 provided outside the inner layer 1 is made by dispersing an X-ray contrast agent made of white bismuth in a synthetic resin. As this synthetic resin, a tetrafluoroethylene copolymer resin is used here as in the inner layer 1, but as described above, other synthetic resins can also be used. The white bismuth compound is a white bismuth mixture consisting of bismuth oxide, bismuth nitrate, and bismuth sulfate, and has a bismuth content of 83 to 88% by weight. The mixture is dispersed and blended into the synthetic resin to cover the inner layer 1. The white bismuth compound is heat resistant and has good biocompatibility.

前記中間層2の外側には、前記と同様の合成樹脂内に粒
径0.05〜1.0μmの酸化チタンを0.5〜2.0
重量%分散配合した外側層3を被覆している。
On the outside of the intermediate layer 2, 0.5 to 2.0 μm of titanium oxide with a particle size of 0.05 to 1.0 μm is contained in the same synthetic resin as above.
It is coated with an outer layer 3 which is dispersed in weight percent.

中間層2及び外側層3への前記配合は、熱可塑性合成樹
脂に配合物を分散配合させるための公知の方法によって
行うことは勿論である。
Needless to say, the above-mentioned compounding into the intermediate layer 2 and the outer layer 3 is carried out by a known method for dispersing and blending the compound into a thermoplastic synthetic resin.

かかる造影剤入チューブは、中間層2に白色ビスマス化
合物からなるX線造影剤が分散されているため外観は白
色を呈していて、カテーテル等として人体に使用するに
際して違和感なく使用することができる。また紫外線に
よって黄変しやすい白色ビスマス化合物ではあるものの
、前記黄変の原因である紫外線は外側層3の酸化チタン
によって透過が防止されるために前記白色ビスマスには
至らず、したがって前記白色ビスマスの黄変が防止され
、造影剤入チューブの白色が長期にわたって維持される
Such a contrast agent-containing tube has a white appearance because an X-ray contrast agent made of a white bismuth compound is dispersed in the intermediate layer 2, and can be used without discomfort when used in the human body as a catheter or the like. Furthermore, although it is a white bismuth compound that is easily yellowed by ultraviolet rays, the ultraviolet rays that cause yellowing are prevented from passing through by the titanium oxide in the outer layer 3, and therefore do not reach the white bismuth. Yellowing is prevented and the white color of the contrast agent tube is maintained for a long period of time.

中間層2の白色ビスマス化合物の配合率が3重量%に満
たないときには、造影機能が低下するとともに白色の程
度も低下する一方、3重量%以上になると造影機能と着
色機能は満足できるものの25重量%を超えるとコスト
が大になる。また、外側層3では酸化チタンを0.5〜
2.0重量%分散配合しているが、これが0.5重量%
に満たないときには紫外線透過抵抗性が小さくなって中
間層2の黄変の原因となり、また2、0重量%を超える
とコスト高になる。
When the blending ratio of the white bismuth compound in the intermediate layer 2 is less than 3% by weight, the contrast function and the degree of whiteness decrease, while when it exceeds 3% by weight, the contrast function and coloring function are satisfactory, but 25% by weight. If it exceeds %, the cost will increase. In addition, the outer layer 3 contains titanium oxide from 0.5 to
2.0% by weight is dispersed, but this is 0.5% by weight.
When the content is less than 2.0% by weight, the ultraviolet transmission resistance decreases, causing yellowing of the intermediate layer 2, and when it exceeds 2.0% by weight, the cost increases.

発明者らは、内側層1に四ふっ化エチレン共重合樹脂を
使用し、85重量%の四ふっ化エチレン共重合樹脂に、
ビスマス含有率85重量%の前記白色ビスマス混晶物を
15重量%分分散会して中間層2を構成するとともに、
酸化チタン1.0重量%を四ふっ化エチレン共重合樹脂
に分散配合して外側層3とした造影剤人チニーブを作っ
た。このチューブの外観、特に白色度の変化を実験した
ところ、このチューブは戸外曝露試験1力月後も変色せ
ず、表面の滑らかさも維持されていたのに対して、前記
外側層3が存在せず前記内側層1と中間層2のみの二重
の造影剤入チューブは1日で黄変した。
The inventors used a tetrafluoroethylene copolymer resin for the inner layer 1, and added 85% by weight of the tetrafluoroethylene copolymer resin to
The white bismuth mixed crystal having a bismuth content of 85% by weight is dispersed in an amount of 15% by weight to constitute the intermediate layer 2, and
Contrast agent Tinib, which was used as the outer layer 3, was prepared by dispersing 1.0% by weight of titanium oxide in a tetrafluoroethylene copolymer resin. When we tested the appearance of this tube, especially changes in whiteness, we found that this tube did not change color even after one month of outdoor exposure test, and the surface remained smooth, whereas the outer layer 3 was not present. The double contrast medium-containing tube containing only the inner layer 1 and intermediate layer 2 turned yellow within one day.

また、各層1.2.3の素材として、前記四ふっ化エチ
レン共重合樹脂に代えて、四ふっ化エチレンー六ぶつ化
プロピレン共重合樹脂、四ふっ化エチレンパーフルオロ
アルキルビニルエーテル共重合樹脂、4ふっ化エチレン
樹脂、ふっ化ビニリデン樹脂及び他のふっ素樹脂を用い
たところ前記同様の良好な結果を得た。
In addition, as the material for each layer 1.2.3, in place of the above-mentioned tetrafluoroethylene copolymer resin, tetrafluoroethylene-hexapropylene copolymer resin, tetrafluoroethylene perfluoroalkyl vinyl ether copolymer resin, tetrafluoroethylene perfluoroalkyl vinyl ether copolymer resin, Good results similar to those described above were obtained using ethylene fluoride resin, vinylidene fluoride resin, and other fluororesins.

〔発明の効果〕〔Effect of the invention〕

以上説明したように、この発明では、中間層にはビスマ
ス化合物からなるX線造影剤が分散されているため造影
効果が高く、また外側層に紫外線透過抵抗性をもたせて
いるため、中間層への紫外線の到達を抑制するから、前
記ビスマス化合物の黄変を防止してチューブを白色に維
持する。
As explained above, in this invention, an X-ray contrast agent made of a bismuth compound is dispersed in the intermediate layer, so the contrast effect is high, and since the outer layer has UV transmission resistance, Since it suppresses the arrival of ultraviolet rays, the bismuth compound is prevented from yellowing and the tube remains white.

外側層の紫外線透過抵抗性を酸化チタンにより付与し、
これを合成樹脂内に分散させて外側層を構成すると、酸
化チタンは紫外線透過抵抗性が高いほか、前記ビスマス
化合物も同様であるが融点も高いために、中間層及び外
側層を構成する合成樹脂として、熱可望性であり且つ生
体適合性がよいふっ素樹脂を使用できる。このため、各
層の形成が容易で且つ人体への使用に適するばかりか、
高温殺菌にも供し得る造影別人チューブとすることがで
きる。
Titanium oxide imparts ultraviolet transmission resistance to the outer layer,
When dispersed in a synthetic resin to form the outer layer, titanium oxide has high ultraviolet transmission resistance, and like the bismuth compound described above, it also has a high melting point, so the synthetic resin forming the intermediate and outer layers As a material, a fluororesin which is thermoplastic and has good biocompatibility can be used. For this reason, each layer is not only easy to form and suitable for use on the human body, but also
It can be made into a contrast tube that can also be subjected to high temperature sterilization.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は造影別人チューブの実施例を示す拡大横断面図
である。 ■・・・内側層、2・・・中間層、3・・・外側層、4
・・・流体通路。
FIG. 1 is an enlarged cross-sectional view showing an embodiment of the contrast tube. ■...Inner layer, 2...Middle layer, 3...Outer layer, 4
...Fluid passage.

Claims (2)

【特許請求の範囲】[Claims] (1)内部に流体通路が形成された管状合成樹脂からな
る内側層の外周に、合成樹脂内にビスマス化合物からな
るX線造影剤を分散させてなる中間層を設け、さらにそ
の外周に、紫外線透過抵抗性を有する外側層を形成した
ことを特徴とする造影剤入チューブ。
(1) An intermediate layer made of an X-ray contrast agent made of a bismuth compound dispersed in the synthetic resin is provided on the outer periphery of the inner layer made of a tubular synthetic resin in which a fluid passage is formed, and an A contrast agent-containing tube characterized by forming an outer layer having penetration resistance.
(2)紫外線透過抵抗性を有する外側層は、合成樹脂内
に酸化チタンを分散させたことを特徴とする第1請求項
記載の造影剤入チューブ。
(2) The contrast agent-containing tube according to claim 1, wherein the outer layer having ultraviolet transmission resistance is made of a synthetic resin in which titanium oxide is dispersed.
JP2021806A 1990-01-31 1990-01-31 Tube with contrast agent Expired - Fee Related JP2839617B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021806A JP2839617B2 (en) 1990-01-31 1990-01-31 Tube with contrast agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021806A JP2839617B2 (en) 1990-01-31 1990-01-31 Tube with contrast agent

Publications (2)

Publication Number Publication Date
JPH03224574A true JPH03224574A (en) 1991-10-03
JP2839617B2 JP2839617B2 (en) 1998-12-16

Family

ID=12065298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021806A Expired - Fee Related JP2839617B2 (en) 1990-01-31 1990-01-31 Tube with contrast agent

Country Status (1)

Country Link
JP (1) JP2839617B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004321395A (en) * 2003-04-23 2004-11-18 Vayu:Kk Medical tube
JP2012130557A (en) * 2010-12-22 2012-07-12 Junkosha Co Ltd Medical tube containing contrast medium

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004321395A (en) * 2003-04-23 2004-11-18 Vayu:Kk Medical tube
JP2012130557A (en) * 2010-12-22 2012-07-12 Junkosha Co Ltd Medical tube containing contrast medium

Also Published As

Publication number Publication date
JP2839617B2 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
US3608555A (en) Radio opaque and optically transparent tubing
US3618614A (en) Nontoxic radiopaque multiwall medical-surgical tubings
US5908413A (en) Radiopaque catheter and method of manufacture thereof
US3529633A (en) X-ray opaque tubing having a transparent stripe
JP3234927B2 (en) Non-polyvinyl chloride co-extruded medical grade port tube
US4657024A (en) Medical-surgical catheter
US4054139A (en) Oligodynamic catheter
US3749134A (en) Radiographically opaque plastic tubing
AU638936B2 (en) Nylon-peba copolymer catheter
EP0807444B1 (en) Catheter reinforcing braids
EP0824932A2 (en) Arterial catheter and catheter/needle assembly with improved flow characteristics and method for its use
DE3726064A1 (en) PACKING UNIT FOR MEDICAL PURPOSES
EP0566690A1 (en) Torque resistant tubing.
US20080119825A1 (en) Catheter and Process for Producing the Catheter
CA2340746A1 (en) Medical devices with echogenic coatings
WO1993023108A2 (en) Coextruded medical grade port tubing
JPH0263466A (en) Swellable multilayyer cannula
US5733496A (en) Electron beam irradiation of catheters to enhance stiffness
US4266542A (en) EVA Formulation having improved properties
JPH03224574A (en) Tube containing contrast media
US5085863A (en) Tube provided with a white bismuth salt containing bismuth compound mixture as X-ray opaque agent
JPH0399674A (en) Tube containing contrast medium
JPH02252466A (en) Contrast medium-containing tube
JP3001609B2 (en) Tube with contrast agent
JPH02142577A (en) Tube containing contrast medium

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees